Brod SA - Search Results

1

Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosis.

Brod SA, Kerman RH, Nelson LD, Marshall GD Jr, Henninger EM, Khan M, Jin R, Wolinsky JS. Brod SA, et al. Mult Scler. 1997 Feb;3(1):1-7. doi: 10.1177/135245859700300101. Mult Scler. 1997. PMID: 9160341 Clinical Trial.

2

Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.

Brod SA, Marshall GD Jr, Henninger EM, Sriram S, Khan M, Wolinsky JS. Brod SA, et al. Neurology. 1996 Jun;46(6):1633-8. doi: 10.1212/wnl.46.6.1633. Neurology. 1996. PMID: 8649562

3

Multiple sclerosis: clinical presentation, diagnosis and treatment.

Brod SA, Lindsey JW, Wolinsky JS. Brod SA, et al. Am Fam Physician. 1996 Sep 15;54(4):1301-6, 1309-11. Am Fam Physician. 1996. PMID: 8816574 Review.

4

Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.

Brod SA, Khan M. Brod SA, et al. J Autoimmun. 1996 Feb;9(1):11-20. doi: 10.1006/jaut.1996.0003. J Autoimmun. 1996. PMID: 8845048

5

IFN-beta 1b treatment of relapsing multiple sclerosis has no effect on CD3-induced inflammatory or counterregulatory anti-inflammatory cytokine secretion ex vivo after nine months.

Brod SA, Nelson LD, Khan M, Wolinsky JS. Brod SA, et al. Int J Neurosci. 1997 Jun;90(1-2):135-44. doi: 10.3109/00207459709000633. Int J Neurosci. 1997. PMID: 9285295 Clinical Trial.

6

Increased in vitro induced CD4+ and CD8+ T cell IFN-gamma and CD4+ T cell IL-10 production in stable relapsing multiple sclerosis.

Brod SA, Nelson LD, Khan M, Wolinsky JS. Brod SA, et al. Int J Neurosci. 1997 Aug;90(3-4):187-202. doi: 10.3109/00207459709000638. Int J Neurosci. 1997. PMID: 9352427 Review.

7

Ingested interferon alpha induces Mx mRNA.

Brod SA, Nelson L, Jin R, Wolinsky JS. Brod SA, et al. Cytokine. 1999 Jul;11(7):492-9. doi: 10.1006/cyto.1998.0450. Cytokine. 1999. PMID: 10419650

8

Ingested IFN-alpha: results of a pilot study in relapsing-remitting MS.

Brod SA, Lindsey JW, Vriesendorp FS, Ahn C, Henninger E, Narayana PA, Wolinsky JS. Brod SA, et al. Neurology. 2001 Sep 11;57(5):845-52. doi: 10.1212/wnl.57.5.845. Neurology. 2001. PMID: 11552015 Clinical Trial.

9

Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosis.

Brod SA, Khan M, Bright J, Sriram S, Marshall GD Jr, Henninger EM, Kerman RH, Wolinsky JS. Brod SA, et al. Ann Neurol. 1995 Apr;37(4):546-9. doi: 10.1002/ana.410370418. Ann Neurol. 1995. PMID: 7717692

10

Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis.

Brod SA, Khan M, Kerman RH, Pappolla M. Brod SA, et al. J Neuroimmunol. 1995 Apr;58(1):61-9. doi: 10.1016/0165-5728(94)00188-t. J Neuroimmunol. 1995. PMID: 7537281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters